Tariffs: Trump says tariffs on generic medicines will rise to 100 per cent from 2028, and then to 200 per cent
President wants to bring production back to the US
(Il Sole 24 Ore Radiocor) - The President of the United States, Donald Trump, has announced that, from August 2028, generic medicines will be subject to 100 per cent tariffs: a measure which, according to him, aims to bring pharmaceutical production back to US soil.
“From 1 August 2026, all generic medicines imported into the United States will continue to be subject to zero per cent tariffs for a period of two years; thereafter, these tariffs will rise to 100 per cent for one year, before increasing to 200 per cent,” he wrote on the Truth platform yesterday evening. Until now, generics had been exempt from the US tariffs on pharmaceutical products announced in April, which can reach up to 100 per cent. However, the US President had given his Secretary of Commerce a year to review the situation and, if necessary, recommend new measures regarding the import of generic medicines. “This measure aims to bring the production of generic medicines back to the United States, penalising companies that decide not to build factories and facilities within the set timeframe,” Trump wrote, adding that the measures already in place for other medicines will remain “unchanged”.
